Skip to main content
CME
NASDAQ Crypto Assets

CME Group Reports Record 2025 Financials, Declares Substantial Dividends, and Wins Class Action Lawsuit

Arie Shkolnikov · Analysis by Wiseek AI
Sentiment info
Positive
Importance info
8
Price
$315.69
Mkt Cap
$114.112B
52W Low
$247.08
52W High
$322.569
52W Position info
28% above low
Off High info
2.1% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

CME sits 28% above its 52-week low of $247.08.

Summary

CME Group reported record financial results for 2025, including significant increases in revenue and net income, and declared a substantial annual variable dividend of $6.15 per share, alongside a favorable jury verdict in a class action lawsuit.


Key Events · Earnings and Guidance · CME

  • Record 2025 Financial Performance

    Reported record total revenues of $6.52 billion and net income of $4.07 billion, with diluted EPS of $11.16, reflecting strong year-over-year growth.

  • Substantial Dividend Declarations

    Declared a regular quarterly dividend of $1.30 per share and a significant annual variable dividend of $6.15 per share, payable March 26, 2026.

  • Favorable Legal Outcome

    A jury returned a unanimous verdict in favor of the company on July 25, 2025, in a class action lawsuit, reducing potential legal liabilities.

  • Share Repurchase Program Activity

    Repurchased $264.1 million of Class A common stock in 2025, with $2.7 billion remaining under the existing authorization.


Analysis · CME · Crypto Assets

This 10-K filing confirms CME Group's strong financial performance for 2025, building on the preliminary results announced earlier. The company achieved record total revenues of $6.52 billion and net income of $4.07 billion, reflecting significant year-over-year growth. Key highlights include a 41% increase in investment income and robust performance across its derivatives and cash markets businesses. The declaration of a $1.30 per share quarterly dividend and a substantial $6.15 per share annual variable dividend demonstrates a strong commitment to returning capital to shareholders. Furthermore, the unanimous jury verdict in favor of CME Group in a class action lawsuit removes a significant legal overhang, contributing positively to the company's risk profile. These combined factors reinforce a positive outlook for the company, especially as it continues its strategic initiatives like the Google Cloud migration and expansion into new product areas.

At the time of this filing, CME was trading at $315.69 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $114.1B. The 52-week trading range was $247.08 to $322.57. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CME - Latest Insights

CME
Jul 22, 2026, 7:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $239.87
Real-time Price: $254.69 info
Change: +$14.82 (+6%) info
Market Cap: $92.514B info
CME
Jul 22, 2026, 7:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $240.00
Real-time Price: $254.69 info
Change: +$14.69 (+6%) info
Market Cap: $92.514B info
CME
Jul 09, 2026, 11:45 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $236.97
Real-time Price: $254.69 info
Change: +$17.72 (+7%) info
Market Cap: $92.514B info
CME
Jul 02, 2026, 7:30 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $233.16
Real-time Price: $254.69 info
Change: +$21.53 (+9%) info
Market Cap: $92.514B info
CME
Jun 23, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $245.45
Real-time Price: $254.69 info
Change: +$9.24 (+4%) info
Market Cap: $92.514B info